Summary
Abundant evidence has shown that tumor growth and metastasis are dependent upon tumor angiogenesis (TA). TA refers to the growth of new vessels toward and within the tumor. Until TA occurs, tumors grow no larger than 2–4 mm in diameter. Also, TA is necessary at the beginning and at the end of the metastatic cascade of events. Thus, it seems reasonable that increasing intratumoral microvascular density (iMVD) might correlate with greater tumor aggressiveness, such as a higher frequency of metastases and/or decreased survival. Indeed, in 1991 my colleagues and I reported a statistically significant association between greater incidence of metastases in patients with breast carcinoma and increasing iMVD. Microvessel density was measured with a light microscope in a single area of invasive tumor (200x field or 0.74 mm2) representative of the highest microvessel density (neovascular “hot spot”). This was done after endothelial cells, lining the microvessels, had been highlighted with anti-factor VIII-related antigen/von Willebrand's factor (F8RA/vWF). Subsequent studies by other investigators, using either anti-F8RA/vWF or other relatively vessel-specific reagents such as anti-CD31, have shown that the association of greater tumor aggressiveness with increasing iMVD exists not only in breast carcinoma, but also in other solid tumors. This article reviews the methods of highlighting intratumoral vessels and describes the techniques for counting these vessels for assessing iMVD.
Similar content being viewed by others
References
Brem S, Cotran R, Folkman J: Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 48:347–356, 1972.
Srivastava A, Laidler P, Hughes LE, Woodcock J, Shedden EJ: Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. Eur J Cancer Clin Oncol 22:1205–1209, 1986
Srivastava A, Laidler P, Davies R, Horgan K, Hughes LE: The prognostic significance of tumor vascularity in intermediate-thickness (0.76–4.0 mm thick) skin melanoma. Am J Pathol 133:419–423, 1988
Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis — correlation in invasive breast carcinoma. N Engl J Med 324:1–8, 1991
McComb RD, Jones TR, Pizzo SV, Bigner D: Specificity and sensitivity of immunohistochemical detection of factor VIII/von Willebrand factor antigen in formalin-fixed paraffin-embedded tissue. J Histochem Cytochem 30:371–377, 1982
Gown AM, de Wever N, Battifora H: Microwavebased antigenic unmasking. A revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1:256–266, 1993
Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84:1875–1887, 1992
Bosari S, Lee AKC, DeLellis RA, et al: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755–761, 1992
Longacre TA, Rouse RV: CD31: A new marker for vascular neoplasia. Adv Anat Pathol 1:16–20, 1994
Horak E, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewska K, Harris AL: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340:1120–1124, 1992
Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Caffo O, Barbareschi M, Boracchi P, Marubini E, Pozza F: Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol 12:454–466, 1994
Toi M, Kashitani J, Tominaga T: Tumor angiogenesis is an independent prognostic indicator of primary breast carcinoma. Int J Cancer 55:371–374, 1993
Visscher DW, Smilanetz S, Drozdowicz S, Wykes SM: Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. Analytical Quant Cytolol Histol 15:88–92, 1993
Arihiro K, Inai K, Kurihara K, Takeda S, Kaneko M: Distribution of laminin, type IV collagen, and fibronectin in the invasive component of breast carcinoma. Acta Pathol Jap 43:758–764, 1993
Macchiarini P, Fontanini G, Hardin MJ, Hardin MJ, Squartini F, Angeletti CA: Relation of neovasculature to metastasis of non-small-cell lung cancer. Lancet 340:145–146, 1992
Macchiarini P, Fontanini G, Dulmet E, de Montpreville V, Chapelier AR, Cerrin J, Le Roy Ladurie F, Dartevelle PG: Angiogenesis: an indicator of metastasis in non-small-cell lung cancer invading the thoracic inlet. Ann Thorac Surg 57:1534–1539, 1994
Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, Asano K, Tokuda T, Aizawa S, Ushigome S: Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 168:257–262, 1992
Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401–409, 1993
Fregene TA, Khanuja PS, Noto AC, Gehani SK, Van Egmont EM, Luz DA, Pienta KJ: Tumor-associated angiogenesis in prostate cancer. Anticancer Res 13: 2377–2381, 1993
Brawer MK, Deering RE, Brown M, Preston SD, Bigler SA: Predictors of pathologic stage in prostate carcinoma. Cancer 73:678–687, 1994
Sneige N, Singletary E, Sahin A, et al: Multiparameter analysis of potential prognostic factors in node negative breast cancer patients. Modern Pathol 5:18a, 1992
Sahin AA, Sneige N, Ordonez GN, et al: Tumor angiogenesis detected byUlex europaeus agglutinin 1 lectin (UEA1) and factor VIII immunostaining in node-negative breast carcinoma (NNBC) treated by mastectomy: prediction of tumor recurrence. Modern Pathol 6:19a, 1993
Obermair A, Czerwenka K, Kurz C, Buxbaum P, Schemper M, Sevela P: Influence of tumoral microvessel density on the recurrence-free survival in human breast cancer: preliminary results. Onkologie 17:44–49, 1994
Gasparini G, Weidner N, Bevilacqua P, Maluta S, Boracchi P, Testolin A, Pozza F, Folkman J: Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 55:739–744, 1993
Mikami Y, Tsukuda M, Mochimatsu I, Kokatsu T, Yago T, Sawaki S: Angiogenesis in head and neck tumors. Nip Jib Gak Kai 96:645–50, 1991
Albo D, Granick MS, Jhala N, Atkinson B, Solomon MP: The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck. Ann Plast Surg 32:588–594, 1994
Petruzzelli GJ, Snyderman CH, Johnson JT, Myers EN: Angiogenesis induced by head and neck squamous cell carcinoma xenografts in the chick embryo chorioallantoic membrane model. Ann Otol Rhinol Laryngol 102:215–221, 1993
Vesalainen S, Lipponen P, Talja M, Alhava E, Syrjanen K: Tumor vascularity and basement membrane structure as prognostic factors in T1–2M0 prostatic adenocarcinoma. Anticancer Res 14:709–714, 1994
Saclarides TJ, Speziale NJ, Drab E, Szeluga DJ, Rubin DB: Tumor angiogenesis and rectal carcinoma. Dis Colon Rectum 37:921–926, 1994
Olivarez D, Ulbright T, DeRiese W, Foster R, Reister T, Einhorn L, Sledge G: Neovascularization in clinical stage A testicular germ cell tumor: prediction of metastatic disease. Cancer Res 54:2800–2802, 1994
Hollingsworth HC, Steinberg SM, Kohn E, Bryant B, Merino MJ: Tumor angiogenesis in advanced stage ovarian cancer. Mod Pathol 7:89a (Abst#514), 1994
Jaeger TM, Weidner N, Chew K, Moore DH, Kerschmann RL, Waldman FM, Carroll PR: Tumor angiogenesis and lymph node metastases in invasive bladder carcinoma. J Urol 151:348A (#482), 1994
Barnhill RL, Fandrey K, Levy MA, Mihm MC, Hyman B: Angiogenesis and tumor progression of melanoma. Quantitation of vascularity in melanocytic nevi and cutaneous melanoma. Lab Invest 67:331–337, 1992
Barnhill RL, Levy MA: Regressing thin cutaneous malignant melanomas (≤1.0 mm) are associated with angiogenesis. Am J Pathol 143:99–104, 1993
Nasser I, Tahan S: Angiogenesis in melanocytic lesions and its relationship to tumor progression. Mod Pathol 6:35A (#190), 1993
Fallowfield ME, Cook MG: The vascularity of primary cutaneous melanoma. J Pathol 164:241–244, 1991
Cockerell CJ, Sonnier G, Kelly L, Patel S: Comparative analysis of neovascularization in primary cutaneous melanoma and Spitz nevus. Am J Dermatopathol 16:9–13, 1994
Graham CH, Rivers J, Kerbel RS, Stankiewicz KS, White WL: Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am J Pathol 145:510–514, 1994
Ewaskow SP, Collins CA, Conrad EU, Gown AM, Schmidt RA: Quantitative assessment of blood vessel density and size in soft-tissue tumors. Mod Pathol 6:6A (#12), 1993
Li VW, Folkerth RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Black PM, Sallan SE, Folkman J: Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumors. Lancet 334:82–86, 1994
Van Hoef MEHM, Knox WF, Dhesi SS, Howell A, Schor AM: Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer 29A:1141–1145, 1993
Hall NR, Fish DE, Hunt N, Goldin RD, Guillou PJ, Monson JRT: Is the relationship between angiogenesis and metastasis in breast cancer real? Surg Oncol 1:223–229, 1992
Weidner N: The relationship of tumor angiogenesis and metastasis with emphasis on invasive breast carcinoma.In: Weinstein RS (ed) Advances in Pathology and Laboratory Medicine. Mosby Year Book, Chicago, 1992, vol 5, pp 101–121
Ordonez NG, Batsakis JG: Comparison ofUlex europaeus I lectin and factor VIII-related antigen in vascular lesions. Arch Pathol Lab Med 108:129–132, 1984
Lee AKC, DeLellis RA, Wolfe HJ: Intramammary lymphatic invasion in breast carcinomas. Evaluation using ABH isoantigens as endothelial markers. Am J Surg Pathol 10:589–594, 1986
Bettelheim R, Mitchell D, Gusterson BA: Immunocytochemistry in the identification of vascular invasion in breast cancer. J Clin Pathol 37:364–366, 1984
Kiyoshi M, Rosai J, Burgdorf WHC: Localization of factor VIII-related antigens in vascular endothelial cells using an immunoperoxidase method. Am J Surg Pathol 4:273–276, 1980
Mukai K, Rosai J: “Factor VIII-related antigen: an endothelial marker.In: DeLellis RA (ed) Advances in Immunohistochemistry. Masson Publishing USA, New York, 1984, pp 253–261
Nagle RB, Witte MH, Martinez AP, Witte CL, Hendrix MJC, Way D, Reed K: Factor VIII-associated antigen in human lymphatic endothelium. Lymphology 20:20–24, 1987
Lee AKC, DeLellis RA, Silverman ML, Wolfe HJ: Perspectives in pathology. Lymphatic and blood vessel invasion in breast carcinoma: a useful prognostic indicator. Hum Pathol 17:984–987, 1986
Svanholm H, Nielsen K, Hauge P: Factor VIII-related antigen and lymphatic collecting vessels. Virchows Arch [Pathol Anat] 404:223–228, 1984
Ordonez NG, Brooks T, Thompson S, Batsakis JG: Use ofUlex europaeus agglutinin I in the identification of lymphatic and blood vessel invasion in previously stained microscopic slides. Am J Surg Pathol 11:543–550, 1987
Jain RK: Delivery of novel therapeutic agents in tumors: physiologic barriers and strategies. J Natl Cancer Inst 81:570–576, 1989
Tanigawa N, Kanazawa T, Satomura K, et al: Experimental study on lymphatic vascular changes in the development of cancer. Lymphology 14:149–154, 1981
Zeidman I, Copeland B, Warren S: Experimental studies on the spread of cancer in the lymphatic system. II. Absence of lymphatic supply in carcinoma. Cancer 8:123–127, 1955
Gilchrist RK: Surgical management of advanced cancer of the breast. Arch Surg 61:913–929, 1950
Papadimitriou JM, Woods AE: Structural and functional characteristics of the microcirculation in neoplasms. J Pathol 116:65–72, 1975
Barsky SH, Baker A, Siegal GP, Togo S, Liotta LA: Use of anti-basement membrane antibodies to distinguish blood vessel capillaries from lymphatic capillaries. Am J Surg Pathol 7:667–677, 1983
Schlingemann RO, Rietveld FJR, Kwaspen F, van de Kerkhof PCM, de Waal RMW, Ruiter DJ: Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am J Pathol 138:1335–1347, 1991
Traweek ST, Kandalaft PL, Mehta P, Battifora H: The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol 96:25–31, 1991
Herlyn M, Clark WH, Rodeck U, Mancianti ML, Jambrosic J, Koprowski H: Biology of tumor progression in human melanocytes. Lab Invest 56:461–74, 1987
DeYoung BR, Wick MR, Fitzgibbon JF, Sirgi KE, Swanson PE: CD31: An immunospecific marker for endothelial differentiation in human neoplasms. Appl Immunohistochem 1:97–100, 1993
van de Rijn M, Rouse RV: CD34: A review. Appl Immunohistochem 2:71–80, 1994
Wang JM, Kumar S, Pye D, Haboubi N, Al-Nakib L: Breast carcinoma: comparative study of tumor vasculature using two endothelial-cell markers. J Natl Cancer Inst 86:386–388, 1994
Wang JM, Kumar S, Pye D, van Agthoven AJ, Krupinski J, Hunter RD: A monoclonal antibody detects heterogeneity in vascular endothelium of tumors and normal tissues. Int J Cancer 54:363–370, 1993
Barbareschi M, Gasparini G, Weidner N, Morelli L, Forti S, Eccher C, Fina P, Leonardi E, Mauri F, Bevilacqua P, Dalla Palma P: Microvessel density quantification in breast carcinomas: assessment by manual vs. a computer-assisted image analysis system. Appl Immunohistochem, in press
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weidner, N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Tr 36, 169–180 (1995). https://doi.org/10.1007/BF00666038
Issue Date:
DOI: https://doi.org/10.1007/BF00666038